Prof Derek Hausenloy is a Clinician Scientist with the SingHealth Duke-NUS Academic Clinical Programme and a Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore. He is also Professor, Cardiovascular & Metabolic Disorders Programme, Duke-NUS Medical School and Professor of Cardiovascular Medicine, University College London.

Prof Hausenloy conducts both basic and clinical research in the area of ischaemic heart disease and heart failure. His research focus is on discovering novel therapies for protecting the heart against the detrimental effects of acute ischaemia/reperfusion injury (IRI) in order to prevent the onset of heart failure. He uses a translational approach to cardioprotection ranging from experimental models of acute IRI to proof-of-concept clinical studies in acute myocardial infarction and cardiac bypass surgery patients, and finally to large multi-center randomised clinical trials focused on clinical outcomes. He is also interested in both small animal and clinical cardiac PET and MRI imaging in the context of acute myocardial infarction and cardioprotection.

Prof Hausenloy has been the principal investigator on over 20 research grants, and he has authored over 170 papers.